Top Banner
Prof. David Kirkland Kirkland Consulting
6

Prof. David Kirkland Kirkland Consulting. For many, the frequency of misleading positive results in vitro is unacceptable Where follow-up testing in vivo.

Mar 27, 2015

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Prof. David Kirkland Kirkland Consulting. For many, the frequency of misleading positive results in vitro is unacceptable Where follow-up testing in vivo.

Prof. David KirklandKirkland Consulting

Page 2: Prof. David Kirkland Kirkland Consulting. For many, the frequency of misleading positive results in vitro is unacceptable Where follow-up testing in vivo.

For many, the frequency of misleading positive results in vitro is unacceptable

Where follow-up testing in vivo is not permitted (e.g. cosmetics ingredients in EU) new products may be abandoned and businesses suffer

For other chemicals in vivo follow-up may be triggered by in vitro +ve when not otherwise required◦ Low tonnage industrial chemicals◦ Food flavours and additives

In such cases, unnecessary animal use occurs

Page 3: Prof. David Kirkland Kirkland Consulting. For many, the frequency of misleading positive results in vitro is unacceptable Where follow-up testing in vivo.

ECVAM workshop (Kirkland et al, 2007) identified several “design” issues of mammalian cell tests thought to contribute to high level of misleading positives – including top conc.; extent & measures of cytotoxicity◦ Others will be discussed in Stefan Pfuhler’s group

Proposed revisions to ICH S2 guideline for pharmaceuticals suggested lowering top conc. for non-toxic drugs to 1 mM (Lutz Müller will present)

So are there data to suggest a reduction in the top conc. for non-pharmaceutical chemicals can also be considered?

Page 4: Prof. David Kirkland Kirkland Consulting. For many, the frequency of misleading positive results in vitro is unacceptable Where follow-up testing in vivo.

ECVAM commissioned Jim and Liz Parry to review published literature◦ At what concs. do carcinogens that are –ve in

Ames test give detectable +ve responses in mammalian cells?

◦ Raffaella Corvi will discuss this review◦ I will discuss some of the “key” chemicals from

this review From the 19 chemicals identified (Kirkland et

al, 2008) as giving misleading +ve results in mammalian cells, 12 are only +ve above 1 mM, and 11 are only +ve above 2 mM◦ These would be avoided if lower top conc.

Page 5: Prof. David Kirkland Kirkland Consulting. For many, the frequency of misleading positive results in vitro is unacceptable Where follow-up testing in vivo.

Chemical Lowest +ve concs.

Tert-butylhydroquinone Lowest +ve conc. in CA test not identified, but <100 µg/ml,

i.e. <1 mM

1,3-dihydroxybenzene +ve in CA test 20-80 µg/ml, i.e. from 0.18 mM upwards

Curcumin +ve for MN at 10 µM

Propyl gallate +ve in MLA at 1 µg/ml and in CA at 16 µg/ml,

i.e. at 0.005-0.075 mM

Ethyl acrylate +ve in MLA at 20 µg/ml (0.2 mM)

Eugenol +ve in MLA at 120 nl/ml (approx. 0.73 mM) although only +ve for CA at 300

µg/ml (1.83 mM)

2,4-dichlorophenol +ve in MLA at 40 µg/ml (0.25 mM) and in CA at 0.6 mM

+ve MLA = >GEF; +ve CA = >5% cells with abs

Page 6: Prof. David Kirkland Kirkland Consulting. For many, the frequency of misleading positive results in vitro is unacceptable Where follow-up testing in vivo.

Chemical Lowest +ve concs.

D,L-menthol +ve in CA at 1.6-1.9 mM

Phthallic anyhydride +ve in CA at 10 mM

o-Anthranilic acid +ve in MLA at 886 µg/ml (6.47 mM)

2-ethyl-1,3-hexanediol +ve in CA at 4000 µg/ml (27.4 mM)

Ethionamide +ve in MLA at 500 µg/ml (3 mM) and in CA at 5-8 mM

Benzyl alcohol +ve in MLA and CA at 30-40 mM

Urea +ve in CA at >10 mM

Sodium saccharin +ve in CA at 8000 µg/ml (33.2 mM)

p-Nitrophenol =ve in CA at 1500 µg/ml (10.8 mM)

Sodium xylene sulfonate Equivocal in MLA at 4000 µg/ml (19.1 mM)

Isobutyraldehyde +ve in MLA at 250 µg/ml (3.47 mM) and in CA at 500 µg/ml (6.94 mM)

Sulfisoxazole Weak +ve in MLA at 1000 µg/ml (3.75 mM)